Inspiremd's cguard™ featured in multiple presentations, including a live case demonstration during the leipzig interventional congress january 25-29, 2021

Tel aviv, israel, jan. 26, 2021 (globe newswire) -- inspiremd, inc. (nyse american: nspr), developer of the cguard™ embolic prevention system (eps) for the prevention of the stroke caused by carotid artery disease, announced today multiple presentations regarding cguard eps, including a live demonstration, during the leipzig interventional congress being held virtually from january 25-29, 2021.
NSPR Ratings Summary
NSPR Quant Ranking